ALKS

Vivitrol (naltrexone)

Alcohol dependence and opioid dependence treatment

Quarterly Sales (Approved)

Exp Date

February 12, 2021 (Est)

Amp Volatility Score

N/A

Catalyst Info & Data Links

TITLE: Vivitrol for Alcohol dependence and opioid dependence treatment  Quarterly Sales (Approved)


WHAT IS THE NEXT CATALYST EVENT?

  • Quarterly Sales (Approved)


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • February 21, 2021


PRIOR DATA/EVENTS

PRESS RELEASES

MECHANISM OF ACTION 

  • Vivitrol is an opioid antagonist OR blocking medication. 1-3 

  • Antagonists create a barrier that blocks opioid molecules from attaching to opioid receptors. Antagonists attach to opioid receptors, but do not cause the release of dopamine. They are non-addictive and do not lead to physical dependence. VIVITROL blocks opioid receptors for one month at a time. Patients must be opioid-free before starting VIVITROL.

  • Source

Updated by MV

Vivitrol, ALKS, Alkemes, opioid dependence, alcohol dependence, mental health, ALKS, 

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon